Sort
4,870 grants matching “glp 1”
Critical Path IND-enabling Studies, Regulatory, and Product Development
$464,073Robert Walter Buckheit · Imquest Biosciences · U19 · FY2014 · AI
Alzheimer's Disease Therapeutic
$463,690Trevor P. Castor · Aphios Corporation · R44 · FY2010 · AG
"Subunit Vaccines for Brucella Pathogens"
$463,574David W Pascual · University Of Florida · R01 · FY2014 · AI
Targeting chemoresistant prostate cancer with novel EED inhibitors
$463,429Daqing Wu · Clark Atlanta University · R01 · FY2023 · CA
HIV VACCINE PRODUCTION
$463,287Novartis Vaccines And Diagnostics, Inc. · N01 · FY2000 · AI
Coating to enhance endothelialization after left atrial appendage closure
$463,188Patrick Hwang · Endomimetics, Llc · R43 · FY2017 · HL
Development of a Next Generation Anthrax Vaccine, AV7909
$462,222Sukjoon Park · Emergent Product Development Gaithersbur · U01 · FY2009 · AI
Lipid transport in the intestine
$462,124Judith Storch · Rutgers, The State Univ Of N.J. · R01 · FY2024 · DK
IND-enabling preclinical development of a multipurpose intravaginal ring for the prevention of Herpes, HIV and unintended pregnancy
$462,000Thomas J. Smith · Auritec Pharmaceuticals, Inc. · R33 · FY2022 · AI
Role of autophagy and retromer genes in GLP-1/Notch signaling
$462,000Alicia Melendez · Queens College · R15 · FY2016 · GM
University of Maryland, Baltimore Biomarker Reference Laboratory
$461,999Sanford A Stass · University Of Maryland Baltimore · U24 · FY2016 · CA
Electronic Bypass for Diabetes
$461,875Jiande Chen · University Of Michigan At Ann Arbor · R01 · FY2020 · DK
Lipid transport in the intestine
$461,728Judith Storch · Rutgers, The State Univ Of N.J. · R01 · FY2025 · DK
IND-enabling preclinical development of a multipurpose intravaginal ring for the prevention of Herpes, HIV and unintended pregnancy
$461,550Thomas J. Smith · Auritec Pharmaceuticals, Inc. · R33 · FY2020 · AI
Developing natural compound emodin as a therapy for alcoholic cardiomyopathy
$461,518Wayne E Carver · Acepre, Llc · UT1 · FY2024 · AA
An Innovative Immune Therapy with Antibiotics to Treat Deadly Excess Inflammation in Sepsis and ARDS Induced from Severe Bacterial Infection in Geriatric Patients
$461,487Eugene Roussel · Bioprovar Corporation · U44 · FY2025 · AG
Mechanism of Defective Incretin Action in Beta Cells during Type 2 Diabetes Mellitus
$460,862Mehboob A Hussain · University Of California-Irvine · R01 · FY2025 · DK
Validation of Human Vaginal Tissue Assay for Endocrine Disruptors
$460,766Seyoum Ayehunie · Mattek Corporation · R44 · FY2012 · ES
IND-enabling preclinical development of a multipurpose intravaginal ring for the prevention of Herpes, HIV and unintended pregnancy
$460,634Thomas J. Smith · Auritec Pharmaceuticals, Inc. · R33 · FY2021 · AI
Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes
$460,500Estefania Quesada Masachs · University Of Miami School Of Medicine · R01 · FY2024 · AI
Development, Formulation and Inhalational Delivery of a New Peptide for ILD
$460,448Sreerama Shetty · University Of Texas Hlth Ctr At Tyler · R01 · FY2021 · HL
A novel immunotolerizing therapy for autoimmune vitiligo
$460,375Kanneganti Murthy · Radikal Therapeutics, Inc. · R44 · FY2019 · AR
SURGICAL STUDIES ON METABOLISM OF GI HORMONES
$460,304University Of Texas Medical Br Galveston · R01 · FY2001 · DK
Role of Hypoxia-inducible factor-2a in L-cell nutrient sensing and metabolic homeostasis
$459,942Sadeesh Kumar Ramakrishnan · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK
Role of Hypoxia-inducible factor-2a in L-cell nutrient sensing and metabolic homeostasis
$459,942Sadeesh Kumar Ramakrishnan · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK